UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 -------------------------------------------------------------------------------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): October 28, 2004 Quest Diagnostics Incorporated One Malcolm Avenue Teterboro, NJ 07608 (201) 393-5000 1-12215 (Commission file number) Delaware (State of Incorporation) 16-1387862 (I.R.S. Employer Identification Number) Item 8.01 Other Events On October 28, 2004, Quest Diagnostics Incorporated (the "Company") issued a press release announcing that it and its test kit manufacturing subsidiary, Nichols Institute Diagnostics ("NID"), each received a subpoena from the U.S. Attorney's office for the Eastern District of New York. The subpoenas seek the production of various business records, including documents related to NID's FDA-cleared tests for parathyroid hormone (PTH) levels. The press release is attached hereto as Exhibit 99.1. Item 9.01. Financial Statements and Exhibits c. Exhibit 99.1 Press release issued October 28, 2004 regarding the subpoena received from the Eastern District of New York. Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. October 28, 2004 QUEST DIAGNOSTICS INCORPORATED By: /s/ Michael. E. Prevoznik ------------------------------ Michael E. Prevoznik Senior Vice President and General Counsel